Who owns PMV PHARMACEUTICALS INC?
- Ticker: PMVP
- CUSIP Number: 69353y103
Tip: Access positions for across all investors
Analyze quarterly positions in Pmv Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Pmv Pharmaceuticals stock
Who bought or sold PMV PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
OrbiMed Advisors | 6.5M | $20M | -1% | Dec 2023 |
|
Jpmorgan Chase & Co | 3.9M | $12M | -3% | Dec 2023 |
|
Arrowpoint Asset Management | 2.7M | $8.4M | 904% | Dec 2023 |
|
Euclidean Capital | 2.6M | $8.1M | 0% | Dec 2023 |
|
Vanguard Group | 2.4M | $7.5M | 18% | Dec 2023 |
|
Partner Fund Management | 1.5M | $4.6M | 14% | Dec 2023 |
|
Bank of America Corporation | 1.4M | $4.5M | 867% | Dec 2023 |
|
BML Capital Management | 1.3M | $2.2M | 100% | Mar 2024 |
|
Citadel Advisors | 1.2M | $3.9M | -36% | Dec 2023 |
|
Goldman Sachs Group | 803k | $2.5M | -15% | Dec 2023 |
|
Point72 Asset Management | 750k | $2.3M | 100% | Dec 2023 |
|
Federated Investors | 703k | $2.2M | -10% | Dec 2023 |
|
Vontobel Holding | 686k | $2.1M | 126% | Dec 2023 |
|
EcoR1 Capital | 567k | $1.8M | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 558k | $1.7M | -4% | Dec 2023 |
|
Citigroup | 521k | $1.6M | 42% | Dec 2023 |
|
Barclays | 517k | $1.6M | 10% | Dec 2023 |
|
Jacobs Levy Equity Management | 430k | $1.3M | 100% | Dec 2023 |
|
Baker Bros. Advisors | 322k | $998k | 0% | Dec 2023 |
|
Two Sigma Investments | 279k | $864k | 718% | Dec 2023 |
|
Charles Schwab Investment Management | 259k | $801k | -4% | Dec 2023 |
|
D. E. Shaw & Co | 249k | $770k | 763% | Dec 2023 |
|
M^T Bank Corporation | 198k | $612k | 100% | Dec 2023 |
|
Two Sigma Advisers | 189k | $585k | 386% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 185k | $574k | 9% | Dec 2023 |
|
AQR Capital Management | 158k | $489k | 979% | Dec 2023 |
|
Schonfeld Strategic Advisors | 142k | $440k | 99% | Dec 2023 |
|
UBS Group | 128k | $396k | -11% | Dec 2023 |
|
Bank of New York Mellon | 117k | $199k | -7% | Mar 2024 |
|
Moore Capital Management | 104k | $322k | -66% | Dec 2023 |
|
Fishman Jay A | 80k | $136k | 167% | Mar 2024 |
|
New York Life Investment Management | 73k | $225k | -2% | Dec 2023 |
|
Assenagon Asset Management | 71k | $120k | 0% | Mar 2024 |
|
Rhumbline Advisers | 60k | $185k | -3% | Dec 2023 |
|
Alliancebernstein | 51k | $157k | -6% | Dec 2023 |
|
Walleye Trading Advisors | 50k | $156k | 100% | Dec 2023 |
|
Hsbc Holdings | 39k | $118k | 27% | Dec 2023 |
|
Algert Coldiron Investors | 32k | $100k | 16% | Dec 2023 |
|
Jane Street | 27k | $84k | -30% | Dec 2023 |
|
Amundi | 26k | $68k | 100% | Dec 2023 |
|
HighTower Advisors | 25k | $77k | 0% | Dec 2023 |
|
T. Rowe Price Associates | 25k | $78k | 0% | Dec 2023 |
|
Graham Capital Management | 23k | $71k | 100% | Dec 2023 |
|
SG Americas Securities | 21k | $65k | 100% | Dec 2023 |
|
American International | 19k | $59k | 0% | Dec 2023 |
|
State of Wyoming | 17k | $52k | 100% | Dec 2023 |
|
Principal Financial Group | 16k | $48k | -98% | Dec 2023 |
|
Virtu Financial | 15k | $48k | 100% | Dec 2023 |
|
Cubist Systematic Strategies | 14k | $44k | 100% | Dec 2023 |
|
Independent Advisor Alliance | 13k | $39k | 100% | Dec 2023 |
|
Royal Bank of Canada | 12k | $39k | 84% | Dec 2023 |
|
Wells Fargo & Company | 12k | $37k | 25% | Dec 2023 |
|
Caption Management | 11k | $35k | 100% | Dec 2023 |
|
Florida State Board of Administration | 11k | $35k | 0% | Dec 2023 |
|
Simplex Trading | 10k | $17k | 107% | Mar 2024 |
|
New York State Common Retirement Fund | 10k | $32k | -1% | Dec 2023 |
|
CI Private Wealth | 10k | $31k | 100% | Dec 2023 |
|
Ohio Pers | 8.3k | $26k | 100% | Dec 2023 |
|
Summit Investment Advisors | 3.8k | $12k | 0% | Dec 2023 |
|
Legal & General Group | 3.5k | $11k | 0% | Dec 2023 |
|
Cutler | 2.6k | $4.2k | -50% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 1.6k | $5.0k | -91% | Dec 2023 |
|
Amalgamated Bank | 1.3k | $2.0k | -63% | Mar 2024 |
|
Private Wealth Management Group | 676.00 | $2.1k | 100% | Dec 2023 |
|
CWM | 165.00 | $0 | 100% | Mar 2024 |
|
Pnc Financial Services | 26.00 | $81.000400 | -97% | Dec 2023 |
|
Advisor Group Holdings | 15.00 | $91.999500 | -95% | Dec 2023 |
|
Who sold out of Pmv Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Boxer Capital | Sep 2023 | 3.2M | $19M |
venBio Select Advisor | Sep 2023 | 3.0M | $18M |
Octagon Capital Advisors | Sep 2023 | 904k | $5.6M |
Tri Locum Partners | Sep 2023 | 821k | $5.0M |
Wellington Management Company | Sep 2023 | 543k | $3.3M |
Nextech Invest | Sep 2023 | 421k | $2.6M |
State of Wisconsin Investment Board | Sep 2023 | 81k | $495k |
Trexquant Investment | Sep 2023 | 68k | $419k |
Marshall Wace | Sep 2023 | 58k | $357k |
PDT Partners | Sep 2023 | 42k | $258k |
Denali Advisors | Dec 2023 | 34k | $105k |
Martingale Asset Management | Sep 2023 | 29k | $180k |
Millennium Management | Sep 2023 | 29k | $175k |
MetLife Investment Advisors | Sep 2023 | 22k | $136k |
Mirae Asset Global Investments | Sep 2023 | 17k | $102k |
Virtus ETF Advisers | Sep 2023 | 17k | $102k |
GSA Capital Partners | Sep 2023 | 13k | $80k |
NISA Investment Advisors | Sep 2023 | 3.5k | $21k |
Assetmark | Sep 2023 | 2.2k | $14k |
Metropolitan Life Insurance Company | Sep 2023 | 2.2k | $13k |
China Universal Asset Management | Sep 2023 | 1.3k | $8.0k |
Daiwa Securities Group | Sep 2023 | 132.00 | $1.0k |